€
0. 05
-0
-2.1277%
€
12.46M Market Cap
- P/E Ratio
- Div Yield
49,000 Volume
-0.34 Eps
€ 0.05
Previous Close Want to track 2O9 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Renalytix Plc (2O9) Statistics
Valuation metrics
Market Cap 12.46M
Enterprise value 6.29M
Trailing P/E (ttm) -0.25
Forward P/E -
PEG ratio -
Price/Sales (ttm) 2.32
Price/Book (mrq) -
Enterprise Value/Revenue 2.2
Enterprise Value/EBITDA -0.37
Overview
Shares outstanding 437.02M
Float 363.95M
Shares short -
% Held by insiders 0.27%
% Held by institutions 0.5%
Average volume (10 days) 9.96K
Average volume (90 days) 3.44K
Price summary
52-Week low 0.01
52-Week high 0.13
Beta 1.81
50-Day moving average 0.02
200-Day moving average 0.06
Financials
Fiscal year
Fiscal year ends 30 Jun 2025
Most recent quarter (mrq) 31 Dec 2024
Profitability
Profit margin 0.4%
Operating margin -4.38%
Operational effectiveness
Return on assets -3.34%
Return on equity 2.91%
Income Statement
Revenue (ttm) 2.86M
Revenue per share (ttm) 0.01
Quarterly revenue growth (yoy) 0.03%
Gross profit (ttm) 1.3M
EBITDA -
Net income to common (ttm) -17.27M
Diluted EPS (ttm) -0.03
Quarterly earnings growth (yoy) 0.03%
Balance Sheet
Total cash (mrq) 5.38M
Total cash per share (mrq) 0.01
Total debt (mrq) 5.03M
Total Debt/Equity (mrq) -4.19
Current ratio (mrq) 1.57%
Book value per share (mrq) -0
Cash Flow
Cash flow statement -11.28M
Levered free cash flow (LFCF) -20.4M
